Patterns of NFkB activation resulting from damage, reactive microglia, cytokines, and growth factors in the mouse
Isabella Palazzo1, Lisa Kelly2, Lindsay Koenig2
1Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Abstract:
Müller glia are a cellular source for neuronal regeneration in vertebrate retinas. However, the capacity for retinal regeneration varies widely across species. Understanding the mechanisms that regulate the reprogramming of Müller glia into progenitor cells is key to reversing the loss of vision that occurs with retinal diseases. In the mammalian retina, NFkB signaling promotes glial reactivity and represses the reprogramming of Müller glia into progenitor cells. Here we investigate different cytokines, growth factors, cell signaling pathways, and damage paradigms that influence NFkB-signaling in the mouse retina. We find that exogenous TNF and IL1β potently activate NFkB-signaling in Müller glia in undamaged retinas, and this activation is independent of microglia. By comparison, TLR1/2 agonist indirectly activates NFkB-signaling in Müller glia, and this activation depends on the presence of microglia as Tlr2 is predominantly expressed by microglia, but not other types of retinal cells. Exogenous FGF2 did not activate NFkB-signaling, whereas CNTF, Osteopontin, WNT4, or inhibition of GSK3β activated NFkB in Müller glia in the absence of neuronal damage. By comparison, dexamethasone, a glucocorticoid agonist, suppressed NFkB-signaling in Müller glia in damaged retinas, in addition to reducing numbers of dying cells and the accumulation of reactive microglia. Although NMDA-induced retinal damage activated NFkB in Müller glia, optic nerve crush had no effect on NFkB activation within the retina, whereas glial cells within the optic nerve were responsive. We conclude that the NFkB pathway is activated in retinal Müller glia in response to many different cell signaling pathways, and activation often depends on signals produced by reactive microglia.
Insights
Nuclear factor kappa B (NFkB) signaling in Müller glia impacts retinal regeneration. Various factors activate or suppress NFkB, with microglial involvement crucial for some pathways, offering insights into vision restoration strategies.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Müller glia possess regenerative potential in vertebrate retinas, but species-specific variations exist.
- Understanding Müller glia reprogramming is crucial for treating vision loss from retinal diseases.
- In mammalian retinas, Nuclear Factor kappa B (NFkB) signaling promotes glial reactivity and hinders Müller glia reprogramming.
Purpose of the Study:
- To investigate how cytokines, growth factors, signaling pathways, and damage influence NFkB signaling in mouse retinal Müller glia.
- To elucidate the role of microglia in NFkB activation within the retina.
Main Methods:
- Treatment of undamaged and damaged mouse retinas with various agents including TNF, IL1β, TLR1/2 agonist, FGF2, CNTF, Osteopontin, WNT4, GSK3β inhibitor, dexamethasone, NMDA, and optic nerve crush.
- Assessment of NFkB signaling activation in Müller glia.
- Evaluation of microglial presence and reactivity.
Main Results:
- Exogenous TNF and IL1β potently activated NFkB in Müller glia independently of microglia.
- TLR1/2 agonist indirectly activated NFkB in Müller glia, dependent on microglia.
- CNTF, Osteopontin, WNT4, or GSK3β inhibition activated NFkB in Müller glia without damage, while dexamethasone suppressed it in damaged retinas, reducing cell death and microglial activation.
- NMDA-induced damage activated retinal NFkB, but optic nerve crush did not activate retinal NFkB, though it affected optic nerve glia.
Conclusions:
- The NFkB pathway is activated in retinal Müller glia by diverse cell signaling pathways.
- Microglia-derived signals are often critical for NFkB activation in Müller glia.
- These findings provide insights into regulating Müller glia for potential retinal regeneration therapies.


